prevent hypoglycemia. The mechanisms for this inverse adaptation are not well understood.
23
We utilized highly insulin-sensitive mice, due to adipocyte-specific overexpression of the 24 FOXC2 transcription factor, to study mechanisms of the reversed islet adaptation to increased 25 insulin sensitivity. We found that Foxc2TG mice responded to mild hyperglycemia with 26 insulin secretion significantly lower than that of wild type mice, however when severe 27 hyperglycemia was induced, Foxc2TG mice demonstrated insulin secretion equal to or greater 28 than that of wild type mice. In response to autonomic nervous activation by 2-deoxyglucose, 29 the acute suppression of insulin seen in wild-type mice was absent in Foxc2TG mice 30 suggesting impaired sympathetic signaling to the islet. Basal glucagon was increased in 31 Foxc2TG mice but they displayed severely impaired glucagon responses to cholinergic and 32 autonomic nervous stimuli. These data suggest that the autonomic nerves contribute to the 33 islet adaptation to high insulin sensitivity which is compatible with a neuro-adipo regulation 34 of islet function being instrumental for maintaining glucose regulation.
INTRODUCTION
insulin resistance is a primary defect causing type 2 diabetes (22). As tight glucose regulation 48 is such a fundamental factor for normal energy homeostasis, it would stand to reason that an 49 adaptation to high degrees of insulin sensitivity is required to continue to maintain normal 50 blood glucose levels. This would also imply a consequent inverse relationship between insulin 51 sensitivity and insulin secretion such that higher insulin sensitivity would be expected to 52 result in lower insulin secretion (3, 11, 22) . This was indeed found in a study of elite athletes 53 with high degrees of insulin sensitivity showing that basal and stimulated levels of insulin 54 were decreased compared to sedentary individuals with lower insulin sensitivity when blood 55 glucose levels were equal (6). Similarly, the improved insulin sensitivity induced by weight 56 reduction after bariatric surgery is associated with reduced insulin secretion (18). The 57 mechanistic basis for this "reverse adaptation" to insulin sensitivity has not been 58 characterized. 
209
We then proceeded to investigate glucagon secretion in response to the non-glucose functionally be a safeguard against increased risk for hypoglycemia in high insulin sensitivity.
260
It is known that a degree of expansion of functional beta cell mass partly explains the 261 mechanism by which insulin resistance is compensated for by increased insulin secretion. A mechanism for how the body adapts to increased insulin sensitivity has not been described to 263 date.
264
The findings of this study suggest that the metabolic response to increased systemic insulin 265 sensitivity is a decrease in basal and glucose stimulated insulin secretion at physiological 266 glucose levels. This decreased insulin secretion is therefore appropriate for the ambient level 
313
The finding of altered islet responses to nervous inputs in the lean, highly insulin sensitive autonomic nervous stimulus by 2-DG in females than in males (27). Furthermore, the high 335 degree of insulin sensitivity in the Foxc2 transgenic mouse model is much less pronounced in males (data not shown), making them less suitable for a study on islet adaptation to high 337 degrees of insulin sensitivity. The reasons for this gender difference are not known at present.
338
Another limitation of our study is the lack of definitive information about the absolute beta 339 cell mass in this model of extreme insulin sensitivity.
340
To our knowledge, our study is the first to demonstrate that chronically increased insulin 341 sensitivity affects islet hormone secretion by a mechanism involving alterations to islet 342 morphology and the basal activation state of the branches of the autonomic nervous system.
343
Future studies will need to be performed to determine whether autonomic nervous signaling 344 affects islet hormone secretion in highly insulin sensitive humans.
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